OPPENHEIMER & CO INC - NEWLINK GENETICS CORP ownership

NEWLINK GENETICS CORP's ticker is NLNK and the CUSIP is 651511107. A total of 107 filers reported holding NEWLINK GENETICS CORP in Q3 2016. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.

Quarter-by-quarter ownership
OPPENHEIMER & CO INC ownership history of NEWLINK GENETICS CORP
ValueSharesWeighting
Q3 2017$114,000
-8.8%
11,200
-8.2%
0.00%
-25.0%
Q4 2016$125,000
-43.4%
12,200
-17.0%
0.00%
-33.3%
Q3 2016$221,000
+17.6%
14,700
-12.0%
0.01%0.0%
Q2 2016$188,000
-57.8%
16,700
-31.8%
0.01%
-57.1%
Q1 2016$446,000
-41.1%
24,500
+17.8%
0.01%
-39.1%
Q4 2015$757,000
+52.9%
20,800
+50.7%
0.02%
+53.3%
Q3 2015$495,000
+6.5%
13,800
+31.4%
0.02%
+15.4%
Q2 2015$465,000
+13.4%
10,500
+40.0%
0.01%
+18.2%
Q1 2015$410,000
+37.6%
7,5000.0%0.01%
+22.2%
Q4 2014$298,0007,5000.01%
Other shareholders
NEWLINK GENETICS CORP shareholders Q3 2016
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,987,099$16,115,0002.75%
Redmile Group, LLC 2,096,490$17,003,0000.74%
Virtus ETF Advisers LLC 41,469$336,0000.42%
LexAurum Advisors, LLC 52,207$448,0000.42%
Avoro Capital Advisors LLC 795,412$6,451,0000.42%
NORTHWEST WEALTH MANAGEMENT, LLC 54,282$440,0000.36%
Rhenman & Partners Asset Management AB 181,047$1,468,0000.20%
Perceptive Advisors 450,000$3,650,0000.12%
Baker Brothers Advisors 1,007,273$8,169,0000.07%
Vident Investment Advisory, LLC 150,540$1,221,0000.06%
View complete list of NEWLINK GENETICS CORP shareholders